Cutaneous and subcutaneous inflammatory sclerosis syndromes

Area of Science:

• Dermatology
• Rheumatology
• Pathology

Background:

• Systemic scleroderma and localized scleroderma (morphea) are often distinguished by clinical features like Raynaud's phenomenon and organ involvement.
• Skin biopsy findings in systemic scleroderma and localized scleroderma show comparable inflammatory and sclerotic changes.

Purpose of the Study:

• To evaluate the relationship between systemic scleroderma and localized scleroderma, including eosinophilic fasciitis, morphea profunda, and acral pansclerotic morphea.
• To determine if clinical and laboratory differences are related to variations in the depth and intensity of cutaneous and subcutaneous inflammatory sclerosis.

Main Methods:

• Histopathological examination of skin biopsy specimens from patients with systemic scleroderma, localized scleroderma, eosinophilic fasciitis, morphea profunda, and acral pansclerotic morphea.
• Clinical evaluation for Raynaud's phenomenon, organ involvement, and laboratory abnormalities.

Main Results:

• Histological analysis revealed similar inflammation and sclerosis in the skin across all evaluated conditions.
• A small percentage of patients with localized scleroderma and related conditions exhibited Raynaud's phenomenon, organ involvement, and laboratory abnormalities typical of systemic scleroderma.
• The primary histological difference observed was the depth of the inflammatory and sclerotic changes.

Conclusions:

• Systemic scleroderma and localized scleroderma, along with related conditions, may represent a spectrum of related diseases.
• Observed clinical and laboratory differences might be attributed to variations in the depth, nature, and intensity of cutaneous and subcutaneous inflammatory sclerosis.